BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Nov 22, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

EpiCept NP-1: Interim Phase IIb data

Interim data from 370 evaluable patients in a double-blind Phase IIb trial showed that topical EpiCept NP-1 significantly reduced pain in patients whose cancers were treated with...

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >